Eastman Kodak Co. has released the In-Vivo Multispectral imaging system, designed to assist in advanced research applications. The system is capable of identifying molecular abnormalities that are the origin of disease at a very early stage.
In-vivo molecular imaging allows noninvasive measurement of biological processes within living organisms. The new system incorporates workflow automation and advanced multispectral fluorescence, luminescence, digital X-ray and radioisotopic imaging capabilities for in-vivo imaging of small animals for drug development and life science research.
In-Vivo Multispectral’s computer-controlled multispectral tuning of excitation light enables the identification and separation of multiple fluorochromes and the removal of autofluorescence background. The system generates and analyzes multispectral fluorochrome images with spatially co-registered X-ray and white light images for localization of biological markers in vivo.
The In-Vivo Multispectral system will be available worldwide next spring, the company said.
January 27, 2026 
